APA

Tortajada C., Pérez-Cuevas B., Moreno A., Martínez E., Mallolas J., García F., Valls E., Miró J. M., De Lazzari E. & Gatell J. M. (20020731). Highly active antiretroviral therapy (HAART) modifies the incidence and outcome of visceral leishmaniasis in HIV-infected patients. : Journal of acquired immune deficiency syndromes (1999).

Chicago

Tortajada Cecilia, Pérez-Cuevas Bernardo, Moreno Asuncion, Martínez Esteban, Mallolas Jose, García Felipe, Valls Eugenia, Miró José M, De Lazzari Esther and Gatell José M. 20020731. Highly active antiretroviral therapy (HAART) modifies the incidence and outcome of visceral leishmaniasis in HIV-infected patients. : Journal of acquired immune deficiency syndromes (1999).

Harvard

Tortajada C., Pérez-Cuevas B., Moreno A., Martínez E., Mallolas J., García F., Valls E., Miró J. M., De Lazzari E. and Gatell J. M. (20020731). Highly active antiretroviral therapy (HAART) modifies the incidence and outcome of visceral leishmaniasis in HIV-infected patients. : Journal of acquired immune deficiency syndromes (1999).

MLA

Tortajada Cecilia, Pérez-Cuevas Bernardo, Moreno Asuncion, Martínez Esteban, Mallolas Jose, García Felipe, Valls Eugenia, Miró José M, De Lazzari Esther and Gatell José M. Highly active antiretroviral therapy (HAART) modifies the incidence and outcome of visceral leishmaniasis in HIV-infected patients. : Journal of acquired immune deficiency syndromes (1999). 20020731.